Skip to main content
search

US & EU Payer Engagement Services

Engaging with confidence for optimal market access

Certara’s US and EU Payer Engagement services empower pharmaceutical and biotech companies to strategically interact with health technology assessment (HTA) bodies and payer stakeholders. By leveraging deep expertise and a systematic framework, we ensure your therapies meet the expectations of decision-makers, optimizing pathways to reimbursement and market access.

Strategic framework for payer & HTA engagement

Navigate complex payer ecosystems with certainty

Certara’s approach to US and EU payer engagement is rooted in precision and foresight. To help our clients engage payers, our highly experienced team creates formal and informal communications with health technology assessment (HTA) and payer stakeholders, either nationally or across the EU. Whether engaging with EU-level or national HTA bodies, we develop concise, evidence-informed dossiers and provide strategic guidance to ensure successful appraisals. 

Firsthand knowledge and expertise

Team of former payer executives intimately familiar with HTA and payer decision-making processes

Proven HTA engagement success

Longstanding experience in EUnetHTA joint assessments and reimbursement submissions, e.g.,. AMNOG, NICE, etc. 

Leadership commitment

Dedicated senior leadership on projects

Why choose Certara for payer engagement?

Certara delivers a unique combination of expertise, innovative methodologies, and proven results. Partner with us to streamline your HTA and payer engagement strategies, ensuring optimal outcomes and accelerated access to global markets.

Contact us

27

Years in HEOR and Market Access

40

Submission projects led in the past 3 years

80

Specialized consultants and strategists

20

Markets for economic model development

Connect with Certara’s payer engagement experts

Whether you’re preparing for an HTA appraisal or seeking to refine your value proposition, Certara’s seasoned experts are here to guide you. With a proven track record and unparalleled expertise, we help you navigate payer ecosystems with confidence.

Why contact Certara?

Extensive network of global payer and HTA stakeholders.
Decades of practical experience with regulatory processes.
Proven methodologies for generating actionable insights.

Send an inquiry


FAQs

What is HTA engagement, and why is it important?

HTA engagement involves interacting with health technology assessment bodies to secure reimbursement and market access for therapies.

How does Certara assist with payer engagement?

Certara provides strategic guidance, evidence generation, and expert-led frameworks to navigate payer and HTA decision-making processes.

What is the significance of Joint Clinical Assessments in the EU?

Joint Clinical Assessments streamline the evaluation of new therapies across EU member states, ensuring consistent and efficient approval processes.